CareTrust REIT (CTRE) Cash & Equivalents (2013 - 2026)

CareTrust REIT's Cash & Equivalents history runs 14 years deep, the most recent figure standing at $223.2 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 741.97% year-over-year to $223.2 million in Q1 2026; TTM through Mar 2026 was $223.2 million, a 741.97% increase from a year earlier, with the FY2025 full-year figure at $198.0 million, down 7.38% from the prior year.
• Cash & Equivalents rose to $223.2 million in Q1 2026 per CTRE's latest filing, from $198.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $712.5 million in Q3 2025 and bottomed at $1.1 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $198.0 million (2025), against an average of $200.3 million.
• Across the five-year window, Cash & Equivalents slumped 96.22% in 2023 and jumped 43143.14% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $13.2 million in 2022, then surged by 2134.39% to $294.4 million in 2023, then dropped by 27.38% to $213.8 million in 2024, then declined by 7.38% to $198.0 million in 2025, then rose by 12.71% to $223.2 million in 2026.
• Per Business Quant, the three latest CTRE Cash & Equivalents figures stand at $223.2 million (Q1 2026), $198.0 million (Q4 2025), and $712.5 million (Q3 2025).